IMCD N.V. (GB:0QVU)
LSE:0QVU
0QVU Stock Chart & Stats
€79.29
-€2.17(-1.56%)
At close: 4:00 PM EST
€79.29
-€2.17(-1.56%)
Day’s Range― - ―
52-Week Range€68.18 - €127.75
Previous CloseN/A
Volume6.76K
Average Volume (3M)48.30K
Market Cap
€4.91B
Enterprise Value€6.37B
Total Cash (Recent Filing)€238.59M
Total Debt (Recent Filing)€1.70B
Price to Earnings (P/E)21.0
Beta0.90
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.76
Shares Outstanding59,107,998
10 Day Avg. Volume26,855
30 Day Avg. Volume48,298
Financial Highlights & Ratios
PEG Ratio-0.86
Price to Book (P/B)2.24
Price to Sales (P/S)0.96
P/FCF Ratio14.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€96.17Price Target Upside21.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)5.31
Revenue Forecast (FY)€5.00B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow ConversionConsistent near one-to-one free cash flow to net income and a 2025 rebound signal durable cash generation. This supports dividends, organic investment, and potential deleveraging capacity, providing financial resilience even if margins or revenue face short-term pressure.
Diversified Specialty-distribution ModelA broad product portfolio, deep end-market diversification, and local technical teams create sticky customer relationships and multiple revenue levers. Value-added formulation and regulatory support strengthen competitive advantage and reduce single-market exposure over the medium term.
Multi-year Top-line Expansion TrendSustained revenue expansion through 2024 demonstrates structural market demand and effective dealer/partner coverage. The 2025 dip appears cyclical; the prior multi-year growth run supports a baseline for recovery and cross-sell-led revenue resilience over several quarters.
Bears Say
Margin Deterioration In 2025Material gross- and operating-margin erosion reduces the company's earnings power and cash-flow cushion. If margin pressure persists from product mix, pricing or input costs, it will constrain reinvestment, margin recovery, and the ability to absorb cost shocks over the medium term.
Rising Leverage Reduces FlexibilityHigher debt-to-equity in the high-0.7x/0.8x range limits balance-sheet optionality, increasing financing risk and reducing capacity for bolt-on M&A or cyclical cushioning. Elevated leverage can raise interest costs and constrain strategic investments across a multi-quarter horizon.
Declining Earnings Quality And ROEA ~24% EPS contraction and a downward ROE trend signal weakening profitability and capital efficiency. This undermines the firm's ability to generate returns from equity and may limit reinvestment capacity or require operational fixes to restore sustainable earnings growth over the medium term.
IMCD N.V. News
0QVU FAQ
What was IMCD N.V.’s price range in the past 12 months?
IMCD N.V. lowest share price was €68.18 and its highest was €127.75 in the past 12 months.
What is IMCD N.V.’s market cap?
IMCD N.V.’s market cap is €4.91B.
When is IMCD N.V.’s upcoming earnings report date?
IMCD N.V.’s upcoming earnings report date is Apr 30, 2026 which is in 34 days.
How were IMCD N.V.’s earnings last quarter?
IMCD N.V. released its earnings results on Feb 18, 2026. The company reported €1.76 earnings per share for the quarter, missing the consensus estimate of €2.39 by -€0.63.
Is IMCD N.V. overvalued?
According to Wall Street analysts IMCD N.V.’s price is currently Undervalued.
Does IMCD N.V. pay dividends?
IMCD N.V. does not currently pay dividends.
What is IMCD N.V.’s EPS estimate?
IMCD N.V.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IMCD N.V. have?
IMCD N.V. has 59,107,998 shares outstanding.
What happened to IMCD N.V.’s price movement after its last earnings report?
IMCD N.V. reported an EPS of €1.76 in its last earnings report, missing expectations of €2.39. Following the earnings report the stock price went down -11.296%.
Which hedge fund is a major shareholder of IMCD N.V.?
Currently, no hedge funds are holding shares in GB:0QVU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IMCD N.V.
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chelates, rheology modifiers, solubilisers, silicones, solvents, and functional additives; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
0QVU Stock 12 Month Forecast
Average Price Target
€96.17
▲(21.29% Upside)
Technical Analysis
Options Prices
Currently, No data available
---